Acute liver failure secondary to toxic exposure in children

Alina Grama1,2, Cornel Aldea3, Lucia Burac1

  • 12 Paediatric Clinic, University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania.

Insights

Acute liver failure (ALF) in children is often caused by toxins. While mushroom poisoning leads to high mortality, drug-induced ALF is a growing concern, particularly from acetaminophen overdose.

Area of Science:

  • Pediatric Toxicology
  • Hepatology
  • Environmental Health

Background:

  • Acute liver failure (ALF) is characterized by jaundice, coagulopathy, and hepatic encephalopathy in individuals without pre-existing liver disease.
  • Toxins and medications are common triggers for ALF in pediatric populations.

Purpose of the Study:

  • To identify the primary causes of toxic acute liver failure in children treated at a major pediatric toxicology center in Romania.
  • To analyze trends in toxic ALF etiology from January 2000 to August 2018.

Main Methods:

  • Retrospective analysis of hospital records for pediatric patients diagnosed with toxic ALF.
  • Inclusion criteria: ALF diagnosis following mushroom or drug exposure.

Main Results:

  • 123 pediatric patients with toxic ALF were admitted over 18 years: 89 from mushroom ingestion, 34 from drug exposure.
  • Mushroom poisoning was the leading cause until 2012; drug-induced ALF, particularly from acetaminophen, has increased significantly.
  • Acetaminophen was the most frequent drug implicated in toxic ALF (52.94%).

Conclusions:

  • Mushroom poisoning-related ALF carries a high mortality rate in children and is a significant cause of death.
  • Limited access to emergency liver transplantation poses a challenge for Eastern European pediatric centers.
  • There is a concerning rise in drug-induced ALF, often linked to intentional overdoses or lax prescription practices for hepatotoxic drugs.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
10
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.2K
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
2.1K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
6
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
16
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
950